SCHEMBL11922531

SCHEMBL11922531

Cc1cc(-c2ccc(/N=N/c3cc(S(=O)(=O)O)c4ccccc4c3N)c(C)c2)ccc1/N=N/c1cc(S(=O)(=O)O)c2ccccc2c1N

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SENP2 Q9HC62 6/20 0.79
▸ SENP1 Q9P0U3 5/20 0.79
▸ SUMO2 P61956 5/20 0.79
▸ SUMO1 P63165 5/20 0.79
▸ SENP7 Q9BQF6 5/20 0.79
▸ SENP3 Q9H4L4 3/20 0.79
▸ ALDH1A1 P00352 3/20 0.76
▸ THRB P10828 3/20 0.76
▸ HPGD P15428 3/20 0.76
▸ RECQL P46063 3/20 0.76
▸ ALOX12 P18054 2/20 0.76
▸ CYP3A4 P08684 2/20 0.76
▸ ALOX15 P16050 2/20 0.76
▸ TSHR P16473 2/20 0.76
▸ MAPK1 P28482 2/20 0.76
▸ HSD17B10 Q99714 2/20 0.76
▸ ENPP2 Q13822 4/20 0.72
▸ APP P05067 3/20 0.70
▸ MEN1 O00255 3/20 0.70
▸ KMT2A Q03164 3/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19154084 1.00 SENP2 (0.79) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL19132211 0.93 SENP2 (0.69) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787577 0.90 ALDH1A1 (0.65) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787656 0.88 ALDH1A1 (0.77) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL29473542 0.88 SENP2 (1.00) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL16153272 0.88 SENP2 (1.00) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL9640761 0.88 SENP2 (0.75) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL23787708 0.87 SENP2 (0.74) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL12534467 0.87 SENP2 (0.60) SENP2SENP1SUMO2SUMO1SENP7
SCHEMBL1897261 0.86 ALDH1A1 (1.00) SENP2SENP1SUMO2SUMO1SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed
US-8537304-B2 Liquid crystal display device and manufacturing method therefor HITACHI DISPLAYS, LTD. (JP) 2013-09-17 — — US disclosed
US-8537304-B2 Liquid crystal display device and manufacturing method therefor HITACHI DISPLAYS, LTD. (JP) 2013-09-17 — — US disclosed
US-8237895-B2 Liquid crystal display device and method of manufacturing the same HITACHI DISPLAYS, LTD. (JP) 2012-08-07 — — US disclosed
US-20100289984-A1 LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREFOR MAGNOLIA PURPLE CORPORATION (JP) 2010-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 SENP2 1558/4885SENP1 1087/4885SUMO2 2270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback